Host Jonathan Porter welcomes Husch Blackwell senior counsel Robert Hess to discuss a groundbreaking Ninth Circuit decision that expands False Claims Act exposure in the 340B drug pricing program. With the Adventist Health case challenging long-held assumptions about FCA liability in the 340B context, Rob provides essential guidance for manufacturers, covered entities, contract pharmacies, and payors navigating this evolving risk See more +
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.
Host Jonathan Porter welcomes Husch Blackwell senior counsel Robert Hess to discuss a groundbreaking Ninth Circuit decision that expands False Claims Act exposure in the 340B drug pricing program. ...